LACTULOSA LAINCO E.F.G.


REGISTRATION: 69299 - Medicamento sujeto a prescripción médica

LACTULOSE

Technical specifications


Indications
Indicated for the habitual and chronic constipation, softening of the faeces and facilitation of the defecation in patients with haemorrhoids, anal fissures, fistulas, and rectum/anal post-surgery.
Indicated for the treatment and prevention of the chronic portal systemic encephalopathy.


Composition
Per sachet of 15 ml:

Lactulose: 10 g
Galactose:< 1,5 g
Lactose: <1,0 g
Epilactose: <1,0 g
Tagatose: < 0,4 g
Water c.s

Each 5 ml of solution contains:
Lactulose: 3,33 g
Galactose: <0,50 g
Lactose: <0,33 g
Epilactose: <0,33 g
Tagatose: <0,13 g
Water c.s


Presentation
Lactulosa Lainco E.F.G 10 sachets single-dose (stick pack) 15 ml* - C.N. 659921.1: PVP 2,99 €, PVP IVA 3,11 €
Lactulosa Lainco E.F.G 50 sachets single-dose (stick pack) 15 ml - C.N. 659919.8: PVP 10,58 €, PVP IVA 11,01 €
Lactulosa Lainco E.F.G 200 ml* - C.N. 659922.8: PVP 3,69 €, PVP IVA 3,84 €
Lactulosa Lainco E.F.G 800 ml* - C.N. 659923.5: PVP 8,99 €, PVP IVA 9,35 €

Clinical packagings:
Lactulosa Lainco E.F.G 200 sachets single-dose (stick pack) - C.N. 602684.7
Lactulosa Lainco E.F.G 800 ml - C.N. 602685.4

Medication subject to medical prescription. Not included in the offer of the National Health System.
* Included in the offer of the National Health System for treatment and prevention of portosystemic hepatic encephalopathy.